Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN70,5470,561,74
Msft-0,19
Nokia3,59353,610,43
IBM0,04
Mercedes-Benz Group AG68,1268,14-0,38
PFE-0,97
18.05.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 17.05.2024 17:35:18
Pharmagest Interac. (Paris)
Závěr k 17.5.2024 Změna (%) Změna (EUR) Objem obchodů (EUR)
60,30 0,33 0,20 282 026
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 18.05.2024
Popis společnosti
Obecné informace
Název společnostiEquasens SA
TickerEQS
Kmenové akcie:Ordinary Shares
RICEQSE.PA
ISINFR0012882389
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.12.2023 1 240
Akcie v oběhu k 31.12.2023 15 031 235
MěnaEUR
Kontaktní informace
Ulice5 Allee de Saint-Cloud
MěstoVILLERS LES NANCY
PSČ54600
ZeměFrance
Kontatní osoba 
Funkce kontaktní osoby 
Telefon33 383 159 595
Fax33383159805

Business Summary: Equasens SA is formerly known as Pharmagest Interactive SA is a France-based company. The Company is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. It provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. It offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc.);
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Equasens SA revenues increased 3% to EUR219.8M. Net income applicable to common stockholders excluding extraordinary items increased 2% to EUR47M. Revenues reflect Pharmacy segment increase of 4% to EUR162.7M, Other segment increase of 3% to EUR25.9M. Net income was partially offset by Sanitary/ Nursing Homes segment income decrease of 11% to EUR10.4M, Other segment income decrease of 3% to EUR8.7M.
Odvětvová klasifikace
TRBC2009Software
TRBC2012IT Services & Consulting (NEC)
RBSS2004Software
MGINDUSTRYSoftware & Programming
MGSECTORTechnology
NAICSSoftware Publishers
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Software Publishers
NAICS2007Electromedical Apparatus Mfg
NAICS1997Software Publishers
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICPrepackaged Software
SICElectromedical Equipment



  • Poslední aktualizace: 18.05.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardThierry Chapusot6401.01.2010
Group Administrative and Finance Director, Member of the Executive CommitteeFrederique Schmidt-01.01.202301.01.2023
Chief Operating Officer, Member of the Management Board, DirectorGregoire de Rotalier5308.07.2020
General Manager, Member of the Management Board, DirectorDenis Supplisson5422.04.2022